Marker Therapeutics Inc (MRKR)

[BluMarlin1960]

Just remember although it seems like this has been an incredible run, truth is at this stage compared to their peers we should have a 200/300 Mill dollar valuation as we speak [share price approx. $3 to $5.

After news of two maybe three indications starting Phase 11 we could easily be priced by the market in the range of IMGN, TNXP,INO,$7 to $12 not to mention the likes of KITE, JUNO down the road think the CEO of Roche may be looking very hard at us right now.

My premise all along is that we would be bought out at minimum of $10, totally possible at $15 to $20 within the next 18/24 month's.

Be patient we have all made great gains by ordinary stock appreciation...but Tapimmune is by no means an ordinary stock/company.

The market has yet to really embrace TPIV, yet we are getting very close to being able to up-list and that would I believe move us into the $7, $12 range as KITE and JUNO and recently ADAPTIMMUNE.

When the market fully digest's the totality of Tappimune's science and the live sit will save, their will be no valuation high enough. That coming from someone that lost mother to Ovarian cancer, many of you have experienced a similar loss I am sure.

Think of the 10's/ 100's of millions that have been in our shoes.

GLTA

BLU